Molecular Biological Peculiarities of the Must Cells Secretome of the Lower Limb Skin in Trophic Ulcers of Various Etiologies
https://doi.org/10.18499/2225-7357-2019-8-1-14-24
Abstract
The purpose of this research was to study characteristics of the mast cell (MC) secretome of the skin of the lower extremities in patients with trophic ulcers of various etiologies.
Material and methods. The study included patients with venous, arterial and neurotrophic ulcers, as well as patients with the normal skin of the lower extremities. Skin specimens were stained by toluidine blue using histochemical techniques and Romanowsky–Giemsa staining; immunohistochemical protocols were used to detect MC tryptase and chymase, including the technology of multiple immune-labeling. Skin sections were studied using a ZEISS Axio Imager.A2 microscope (Carl Zeiss, Germany).
Results. In the skin of patients with chronic arterial and, especially, venous insufficiency, the number of protease-containing MCs and chymase expression in the skin increased compared with the similar indicators of the skin without pathological changes. Activation of the protease secretory pathways in MCs was manifested by the release of separate tryptase and chymase-positive granules, and by the formation of granule-containing fragments of the cytoplasm. The group of patients with neurotrophic ulcers was characterized by the most expressed growth in the volume of the MC population in the skin with the increase of their size, activity of the secretory pathways and signs of polymorphism. Infiltration of the skin by MC spread into the epidermis with intensive secretion of proteases into the area of tight junctions and the intercellular matrix of the basal and spinous layers.
Conclusion. MC specific proteases in chronic ulcers of the lower extremities of various etiologies may be used as an informative marker of inflammatory progression degree in the skin not only for diagnostic purposes and monitoring the effectiveness of the performed therapy but also as a promising target for pharmacological agents.
About the Authors
D. A. Atyakshin
Voronezh N.N. Burdenko State Medical University, Voronezh
Russian Federation
Russian Federation
Dmitrii Atyakshin
Research Institute of Experimental Biology and Medicine,
ul. Studencheskaya, 10, Voronezh, 394036
M. V. Aralova
Voronezh N.N. Burdenko State Medical University, Voronezh
Russian Federation
Russian Federation
A. A. Glukhov
Voronezh N.N. Burdenko State Medical University, Voronezh
Russian Federation
Russian Federation
References
1. Атякшин Д. А., Бухвалов И. Б., Тиманн М. Гистохимия ферментов: методическое пособие. Воронеж: Научная книга; 2016. 120 [Atyakshin D, Bukhvalov I, Timann M. Gistokhimiya fermentov: metodicheskoe posobie. Voronezh: Nauchnaya Kniga; 2016] (in Russian).
2. Атякшин Д. А., Бухвалов И. Б., Тиманн М. Протеазы тучных клеток в формировании специфического тканевого микроокружения: патогенетические и диагностические аспекты. Терапия. 2018; 6(24): 128–140 [Atiakshin D, Bukhvalov I, Timann M. Mast cell proteases in specific tissular microenvironment formation: pathogenetic and diagnostical aspects. Therapy. 2018;6(24):128–40] (in Russian).
3. Глухов А. А., Аралова М. В. Патофизиология длительно незаживающих ран и современные методы стимуляции раневого процесса. Новости хирургии. 2015. Т 23.6. 673-679 [Gluhov АА, Aralova MV. Pathophysiology of Persistent Chronic and Current Methods of Stimulation of Wound Process. Novosti Khirurgii. 2015 Dec 5;23(6):673–9] (in Russian). doi: 10.18484/2305-0047.2015.6.673
4. Кондашевская М. В. Тучные клетки и гепарин – ключевые звенья в адаптивных и патологических процессах. Вестник российской академии медицинских наук. 2010; 6: 49–54 [Kondashevskaya M. Mast cells and heparin: key links in adaptive and pathological processes. Vestnik Rossiiskoi akademii meditsinskikh nauk. 2010;6:49–54] (in Russian).
5. Орлов А. И. Прикладная статистика. М.: Экзамен; 2006. 671 [Orlov A. Prikladnaya statistika. Moscow: Ekzamen; 2006] (in Russian).
6. Федорова Е. А., Суфиева Д. А., Григорьев И. П., Коржевский Д. Э. Тучные клетки эпифиза человека. Успехи геронтологии. 2018; 31(4): 484–489 [Fedorova E, Sufieva D, Grigorev I, Korzhevskii D. Mast cells of the human pineal gland. Uspekhi gerontologii. 2018;31(4):484–9] (in Russian).
7. Atiakshin D, Buchwalow I, Samoilova V, Tiemann M. Tryptase as a polyfunctional component of mast cells. Histochemistry and Cell Biology. 2018 Mar 12;149(5):461–77. doi: 10.1007/s00418-018-1659-8
8. Atiakshin D, Samoilova V, Buchwalow I, Boecker W, Tiemann M. Characterization of mast cell populations using different methods for their identification. Histochemistry and Cell Biology. 2017 Feb 27;147(6):683–94. doi: 10.1007/s00418-017-1547-7
9. Buchwalow IB, Boöcker W. Immunohistochemistry: Basics and Methods. 1st ed. London: New York: Springer; 2010.
10. Caughey GH. Mast cell proteases as pharmacological targets. European Journal of Pharmacology. 2016 May;778:44–55. doi: 10.1016/j.ejphar.2015.04.045
11. Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunological Reviews. 2007 Jun;217(1):141–54. doi: 10.1111/j.1600-065x.2007.00509.x
12. Chen L, Gao B, Zhang Y, Lu H, Li X, Pan L, et al. PAR2 promotes M1 macrophage polarization and inflammation via FOXO1 pathway. Journal of Cellular Biochemistry. 2018 Dec 14; doi: 10.1002/jcb.28260 [Epub ahead of print]
13. Corvera CU, Déry O, McConalogue K, Böhm SK, Khitin LM, Caughey GH, et al. Mast cell tryptase regulates rat colonic myocytes through proteinaseactivated receptor 2. Journal of Clinical Investigation. 1997 Sep 15;100(6):1383–93. doi: 10.1172/jci119658
14. de Souza Junior DA, Santana AC, da Silva EZM, Oliver C, Jamur MC. The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis. BioMed Research International. 2015;2015:1–13. doi: 10.1155/2015/142359
15. Dell’Italia LJ, Collawn JF, Ferrario CM. Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling. Circulation Research. 2018 Jan 19;122(2):319–36. doi: 10.1161/circresaha.117.310978
16. Dong X, Geng Z, Zhao Y, Chen J, Cen Y. Involvement of mast cell chymase in burn wound healing in hamsters. Experimental and Therapeutic Medicine. 2012 Nov 27;5(2):643–7. doi: 10.3892/etm.2012.836
17. Dudeck A, Köberle M, Goldmann O, Meyer N, Dudeck J, Lemmens S, et al. Mast cells as protectors of health. Journal of Allergy and Clinical Immunology. 2018 Nov; doi: 10.1016/j.jaci.2018.10.054 [Epub ahead of print]
18. Espinosa E, Valitutti S. New roles and controls of mast cells. Current Opinion in Immunology. 2018 Feb;50:39–47. doi: 10.1016/j.coi.2017.10.012
19. Hallgren J, Pejler G. Biology of mast cell tryptase. FEBS Journal. 2006 Apr 5;273(9):1871–95. doi: 10.1111/j.1742-4658.2006.05211.x
20. Huber M, Cato ACB, Ainooson GK, Freichel M, Tsvilovskyy V, Jessberger R, et al. Regulation of the pleiotropic effects of tissue-resident mast cells. Journal of Allergy and Clinical Immunology. 2019 Feb; doi: 10.1016/j.jaci.2019.02.004. [Epub ahead of print]
21. Krystel-Whittemore M, Dileepan KN, Wood JG. Mast Cell: A Multi-Functional Master Cell. Frontiers in Immunology. 2016 Jan 6;6:1–12. doi: 10.3389/fimmu.2015.00620
22. Lee-Rueckert M, Silvennoinen R, Rotllan N, Judström I, Blanco-Vaca F, Metso J, et al. Mast Cell Activation In Vivo Impairs the Macrophage Reverse Cholesterol Transport Pathway in the Mouse. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011 Mar;31(3):520–7. doi: 10.1161/atvbaha.110.221069
23. Levi-Schaffer F, Piliponsky AM. Tryptase, a novel link between allergic inflammation and fibrosis. Trends in Immunology. 2003 Apr;24(4):158–61. doi: 10.1016/s1471-4906(03)00058-9
24. Lombardo J, Broadwater D, Collins R, Cebe K, Brady R, Harrison S. Hepatic mast cell concentration directly correlates to stage of fibrosis in NASH. Human Pathology. 2019 Apr;86:129–35. doi: 10.1016/j.humpath.2018.11.029 [Epub ahead of print]
25. Molinari JF, Scuri M, Moore WR, Clark J, Tanaka R, Abraham WM. Inhaled tryptase causes bronchoconstriction in sheep via histamine release. American Journal of Respiratory and Critical Care Medicine. 1996 Sep;154(3):649–53. doi: 10.1164/ajrccm.154.3.8810600
26. Mukai K, Tsai M, Saito H, Galli SJ. Mast cells as sources of cytokines, chemokines, and growth factors. Immunological Reviews. 2018 Feb 12;282(1):121–50. doi: 10.1111/imr.12634
27. Pejler G, Åbrink M, Ringvall M, Wernersson S. Mast Cell Proteases. Advances in Immunology. 2007;(95):167–255. doi: 10.1016/s0065-2776(07)95006-3
28. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, et al. Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response. Endocrine Reviews. 2005 Feb;26(1):1–43. doi: 10.1210/er.2003-0025
29. Suttle M-M, Harvima IT. Mast cell chymase in experimentally induced psoriasis. The Journal of Dermatology. 2015 Dec 24;43(6):693–6. doi: 10.1111/1346-8138.13234
30. Ui H, Andoh T, Lee J-B, Nojima H, Kuraishi Y. Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in antipruritic effect of nafamostat mesilate in mice. European Journal of Pharmacology. 2006 Jan;530(1–2):172–8. doi: 10.1016/j.ejphar.2005.11.021
31. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. Journal of Leukocyte Biology. 1997 Mar;61(3):233–45. doi: 10.1002/jlb.61.3.233
32. Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nature Reviews Immunology. 2014 Jun 6;14(7):478–94. doi: 10.1038/nri3690
33. Wilcock A, Bahri R, Bulfone-Paus S, Arkwright PD. Mast cell disorders: From infancy to maturity. Allergy. 2018 Nov 28;74(1):53–63. doi: 10.1111/all.13657
Review
For citations:
Atyakshin D.A., Aralova M.V., Glukhov A.A. Molecular Biological Peculiarities of the Must Cells Secretome of the Lower Limb Skin in Trophic Ulcers of Various Etiologies. Journal of Anatomy and Histopathology. 2019;8(1):14-24. (In Russ.) https://doi.org/10.18499/2225-7357-2019-8-1-14-24
Views:
596
Email this article 